Meet Trinzo at Global Access 2026
21–22 October | The Galmont Hotel, Galway
We’re joining the Global Access conversation to explore how organizations can respond to growing Regulatory complexity, scale Quality effectively, and adopt AI with greater trust & confidence. The ultimate goal? To exchange ideas on how to build agility, efficiency and capacity for innovation while keeping sight of what ultimately matters: better outcomes for patients.
The Trinzo Global Access Pulse
Better decisions. Better outcomes. Better lives.
Across the two days, we’ll be asking delegates where they see the greatest opportunities for progress across Quality, Regulation, Digital Trust and the responsible use of AI.
A few questions connected to the issues being debated on stage. A snapshot of where the MedTech community thinks we should go next. We’ll share what we’re hearing during the event and bring the insights together afterwards.
And we’re planning to make those conversations count in another way too, by connecting participation with support for better lives. Come and share your perspective. We’ll make a donation of €10 to HopeSpace for every completed Pulse. Based in Galway, HopeSpace is a free one to one, in person listening service which supports children and teens who are mourning the loss of someone special in their lives.
Global Access Pulse Report
Request your copy of Pulse Report from Global Access 2026
"*" indicates required fields
Quality. Regulation. Digital Trust. What does better look like beyond 2026?
Global Access brings together the people shaping the future of MedTech Quality and Regulatory Affairs. As expectations increase and the pace of change accelerates, where is the greatest opportunity to move forward?
Panel discussions will explore how MedTech can move faster without compromising confidence, control or patient safety – from regulatory convergence and stronger regulator relationships to Quality at scale, resilience and digital trust.
We believe part of the answer lies in how effectively the industry combines deep Quality and Regulatory expertise with new digital and AI capabilities that strengthen judgement and accelerate progress.
The opportunity is ultimately bigger than efficiency alone: more proactive Quality and Regulatory functions, greater operational agility, faster routes to market and more capacity for MedTech innovation.
These are some of the conversations we’d like to continue at Global Access. If you’re there, we’d love to chat.
Quality at Scale
How can organizations deliver more consistent Quality throughout the lifecycle?
By embedding AI into Quality processes, with human oversight and accountability retained, teams can improve execution, reduce variation, identify issues earlier and support more consistent decisions.
Regulatory Readiness
How can organizations move from reacting to regulatory change to anticipating it?
With governance, traceability, validation and transparency baked-in, AI can strengthen regulatory intelligence, help connect new signals with products and processes, organise evidence and accelerate impact assessment and response.
Resilience & Excellence
How can organizations respond faster to disruption without losing control?
By bringing together data, signals and workflows across Quality, Regulatory, Supply Chain and Operations, AI can help identify emerging issues sooner, assess their impact faster and support more consistent, coordinated action.
Meet us at Global Access
Some of the Trinzo team will be there for the 2 days to exchange ideas and share learnings on the Quality and Regulatory challenges, and discuss opportunities for future resilience and growth within the MedTech sector.
Liam Turley is the CEO and Quality Expert at Trinzo and is based in Galway, Ireland. Liam has worked in the medical device and pharmaceutical industry for over 25 years at global leadership positions, including companies such as Tyco Healthcare, Mallinckrodt, Covidien and Medtronic. With experience spanning the United States and the EU, Liam has led global initiatives in the area of medical device and combination products.
Liam is particularly skilled in quality remediation, and successfully leading companies in resolving notified body major/critical findings, 483s, warning letters and consent decrees. With extensive MDR expertise and a strong understanding of the changes and increased requirements that it brings, he has liaised with multiple notified bodies, competent authorities, the FDA, and ministries of health around the globe.
He holds a bachelor’s degree in microbiology and a master’s degree in biotechnology, in addition to a postgraduate diploma in pharmaceutical manufacturing.
Areas of Expertise:
- Quality Strategy and alignment
- Quality Remediation
- Use of AI in Quality and Regulatory Processes
- Quality Culture
- Coaching and Mentoring Senior Leaders in Quality, Cost of Quality and Change Management
Kathryn is Trinzo’s Head of Client Delivery and is based in Cavan, Ireland.
With over 25 years of experience across financial services, change management, and client engagement, Kathryn brings a strategic, client-focused approach to her role as Trinzo’s Head of Client Delivery. Known for a strong track record in strategic planning, program management, and business transformation, she has successfully partnered with top-tier companies to deliver impactful solutions that address complex challenges.
Kathryn’s leadership style is defined by a commitment to understanding and aligning with client needs. She excels in building trusted relationships, delivering tailored solutions, and navigating the demands of strategic technology and remediation initiatives with a keen focus on risk, quality, and future-proofing. Passionate about creating inclusive environments, she has also pioneered diverse training programs that empower women returning to the workforce, underscoring her dedication to meaningful change.
At Trinzo, Kathryn fosters a culture of collaboration, innovation, and excellence, consistently driving results that benefit clients and position them for sustained success.
Amie is a clinical and regulatory affairs expert with over 30 years’ post-doctoral experience in medical devices, spanning R&D, NPD, quality systems and regulatory compliance.
Formerly Head of Clinical Compliance at BSI, she has contributed extensively to standards and MDCG guidance on clinical investigation and evaluation. She continues to serve as an independent expert for MDCG.
She is also a member of ISO/TC 194 (home of ISO 14155 and ISO 18969) and drafted the original version of ISO 18969. She chairs the Education Committee if ICEPS and is a Fellow of the Regulatory Affairs Professionals Society.
Panel Discussion: Thursday 22 October | 10:00–11:00
Digital Trust: What the Rise of Digital Health Means for Regulations
Liam Turley, CEO at Trinzo, joins Alexander Olbrechts of MedTech Europe and Monika McDole-Russell of Intuitive for this Global Access panel.
For regulated organizations that Trinzo works with, the conversation around Digital Trust is evolving. AI is naturally becoming part of the discussion and questions are moving beyond “Can we use it?” to considerations on how and where it can add real value to Quality and Regulatory operations.
Digital trust isn’t about slowing innovation down. It’s about creating enough confidence to move faster.
• What needs to be in place before leaders can trust AI-supported decisions in Quality and Regulatory environments?
• How do you balance innovation and speed with governance, validation and human accountability?
• Could AI and digital capability change the role of Quality and Regulatory from reactive functions into more proactive business enablers?
This is the thinking behind Trinzo’s INSPIRE Framework, a structured approach that connects AI opportunity with readiness, governance, capability, workflow design, data, implementation and continuous improvement. It’s ultimately about using AI responsibly to strengthen Quality, Regulatory capability and operational excellence.
Download the INSPIRE Framework